Clinical trial
A Phase 2 Study for Transdermal Application of Teriparatide
NCT01011556 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Study for Transdermal Application of Teriparatide
- Lead sponsor
- Eli Lilly and Company
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2009
- Completion date
- September 30, 2011
- Enrollment
- 233 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.